KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Gilead Sciences (GILD) Long-Term Debt Issuances (2016 - 2024)

Historic Long-Term Debt Issuances for Gilead Sciences (GILD) over the last 10 years, with Q4 2024 value amounting to $3.5 billion.

  • Gilead Sciences' Long-Term Debt Issuances rose 34630000.0% to $3.5 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $3.5 billion, marking a year-over-year increase of 24789.16%. This contributed to the annual value of $3.5 billion for FY2024, which is 7494.95% up from last year.
  • As of Q4 2024, Gilead Sciences' Long-Term Debt Issuances stood at $3.5 billion, which was up 34630000.0% from $1.0 million recorded in Q4 2023.
  • Gilead Sciences' Long-Term Debt Issuances' 5-year high stood at $3.5 billion during Q4 2024, with a 5-year trough of $1.0 million in Q4 2023.
  • For the 3-year period, Gilead Sciences' Long-Term Debt Issuances averaged around $1.5 billion, with its median value being $995.0 million (2020).
  • The largest annual percentage gain for Gilead Sciences' Long-Term Debt Issuances in the last 5 years was 34630000.0% (2024), contrasted with its biggest fall of 34630000.0% (2024).
  • Over the past 3 years, Gilead Sciences' Long-Term Debt Issuances (Quarter) stood at $995.0 million in 2020, then tumbled by 99.9% to $1.0 million in 2023, then skyrocketed by 346300.0% to $3.5 billion in 2024.
  • Its Long-Term Debt Issuances stands at $3.5 billion for Q4 2024, versus $1.0 million for Q4 2023 and $995.0 million for Q4 2020.